Frankly - I don't expect any 'big jump' (btw - I don't consider this a big jump here) to be sustained until NNVC actually does get TOX testing started.
Then I expect larger (and generally sustained) increases incrementally each step further down the Clinical Testing pathway they take.
I have never really figured that NNVC would 'jump' to dozens or hundreds of dollars a share before they had some steady revenue coming in,...